Roche receives FDA approval for companion diagnostic tests to identify patients with HER2-positive metastatic gastroesophageal adenocarcinoma eligible for ZIIHERA
Go back to Roche receives FDA approval for companion diagnostic tests to identify patients with HER2-positive metastatic gastroesophageal adenocarcinoma eligible for ZIIHERA| Roche Holding AG Basel American Depositary Shares (AMEX: RHHBY) | Delayed: 55.30 +1.15 (2.12%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $54.15 | 52 Week High | $35.13 | |||
| Open | $55.13 | 52 Week Low | $28.10 | |||
| Day High | $55.59 | P/E | N/A | |||
| Day Low | $55.05 | EPS | $0.00 | |||
| Volume | 1,379,117 | |||||
| Brown & Brown, Inc. (NYSE: RO) | Delayed: 8.49 +0.55 (6.93%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $7.94 | 52 Week High | $8.59 | |||
| Open | $7.94 | 52 Week Low | $7.82 | |||
| Day High | $8.59 | P/E | 6.53 | |||
| Day Low | $7.82 | EPS | $1.30 | |||
| Volume | 42,732 | |||||
| ROGERS CORPORATION (NYSE: ROG) | Delayed: 129.85 +0.08 (0.06%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $129.77 | 52 Week High | $76.55 | |||
| Open | $132.08 | 52 Week Low | $41.92 | |||
| Day High | $132.08 | P/E | 73.36 | |||
| Day Low | $129.52 | EPS | $1.77 | |||
| Volume | 192,023 | |||||
| Roper Industries (NASDAQ: ROP) | Delayed: 365.40 -7.34 (1.97%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $372.74 | 52 Week High | $195.93 | |||
| Open | $372.00 | 52 Week Low | $155.79 | |||
| Day High | $374.15 | P/E | 68.04 | |||
| Day Low | $364.33 | EPS | $5.37 | |||
| Volume | 1,030,926 | |||||
